An update on the relationships between rheumatoid arthritis and atherosclerosis

Zeynep Ozbalkan1, Cumali Efe, Mustafa Cesur

  • 1Department of Rheumatology, Ankara Numune Hospital, Turkey. z.aslar@hotmail.com

Atherosclerosis
|May 1, 2010
PubMed

Insights

Rheumatoid arthritis (RA) patients face higher cardiovascular risks due to chronic inflammation driving atherosclerosis. This review explores the link between RA and the inflammatory processes underlying cardiovascular disease.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease.
  • Cardiovascular events are the leading cause of death in RA patients.
  • Chronic inflammation in RA contributes significantly to atherosclerosis development.

Purpose of the Study:

  • To analyze the complex relationship between rheumatoid arthritis and atherosclerosis.
  • To highlight the role of chronic systemic inflammation in cardiovascular disease progression in RA patients.

Main Methods:

  • Literature review of studies investigating rheumatoid arthritis and atherosclerosis.
  • Analysis of the inflammatory pathways involved in both conditions.

Main Results:

  • Atherosclerosis is an active inflammatory process, not merely lipid accumulation.
  • Shared inflammatory cells like macrophages, monocytes, and T cells are implicated in both RA and atherosclerosis.
  • Chronic systemic inflammation is a key driver of endothelial dysfunction, plaque rupture, and thrombosis in RA.

Conclusions:

  • There is a strong link between rheumatoid arthritis and atherosclerosis, driven by shared inflammatory mechanisms.
  • Understanding these connections is crucial for managing cardiovascular risk in RA patients.
  • Targeting inflammation may be key to preventing cardiovascular events in rheumatoid arthritis.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...